D
Absci Corporation ABSI
$3.90 $0.215.69%
Recommendation
Sell
Prev Close
$3.90
Volume
591,050
Avg Vol (90D)
1,393,560
Market Cap
$442.87M
Dividend & Yield
--
52-Week Range
$1.11 - $6.72
P/E (TTM)
--
EPS (TTM)
-$0.9331
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Cathie Wood's ARK Investment bought 212K shares of Absci today
9/11/2024 - The Fly
Absci (ABSI, $3.99) entered Downtrend as Momentum indicator drops below 0 level on Sep 03, 2024
9/4/2024 - Tickeron - Stocks
Truist Financial Sticks to Its Buy Rating for AbSci (ABSI)
9/3/2024 - TipRanks Financial Blog
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire
8/31/2024 - Insider Monkey
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
8/30/2024 - Fool.com Headlines
Cathie Wood's ARK Investment bought 82.7K shares of Absci today
8/29/2024 - The Fly
11 Penny Stocks That Will Make You A Millionaire
8/27/2024 - Insider Monkey
Absci to Participate in Upcoming Investor Conferences
8/21/2024 - Globe Newswire
Absci Corporation's (NASDAQ:ABSI) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week
8/20/2024 - Simply Wall St
Absci Co. (NASDAQ:ABSI) Short Interest Down 10.0% in July
8/20/2024 - Ticker Report
Absci Corporation (NASDAQ:ABSI) Q2 2024 Earnings Call Transcript
8/19/2024 - Insider Monkey
Absci Co. (NASDAQ:ABSI) Short Interest Update
8/19/2024 - Zolmax
Absci Co. (NASDAQ:ABSI) Short Interest Update
8/19/2024 - Ticker Report
Absci Corp (ABSI) Q2 2024 Earnings Call Transcript Highlights: Revenue Struggles Amid Increased ...
8/18/2024 - GuruFocus
Q2 2024 Absci Corp Earnings Call Transcript
8/18/2024 - GuruFocus
Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript
8/17/2024 - SeekingAlpha
Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript
8/17/2024 - Seeking Alpha: Transcripts
Absci CEO details Sloan Kettering Cancer Center partnership
8/16/2024 - Bizjournals.com - Health Care News
Absci CEO details Sloan Kettering Cancer Center partnership
8/16/2024 - BizJournals.com - Nat'l Business News
Absci (NASDAQ:ABSI) Announces Earnings Results, Misses Estimates By $0.03 EPS
8/16/2024 - Zolmax
Absci (NASDAQ:ABSI) Releases Earnings Results, Misses Expectations By $0.03 EPS
8/16/2024 - Ticker Report
Absci (ABSI, $4.14) entered Uptrend as Momentum indicator ascends above 0 level on Aug 15, 2024
8/16/2024 - Tickeron - Stocks
Buy Rating Justified by ABS-101's Market Potential and Strategic Partnerships
8/15/2024 - TipRanks Financial Blog
TD Cowen Reaffirms Their Buy Rating on AbSci (ABSI)
8/15/2024 - TipRanks Financial Blog
Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates
8/14/2024 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$3.25M
EBITDA (TTM)
-$83.96M
EBIT (TTM)
-$97.76M
Net Income (TTM)
-$92.26M
Balance Sheet
Total Assets (Q)
$255.53M
Total Debt (Q)
$13.33M
Total Liabilities (Q)
$34.04M
Book Value Per Share (Q)
$1.95
Cash Flow
Cash from Operations (TTM)
-$59.99M
Cash from Investing (TTM)
-$36.33M
Cash from Financing (TTM)
$78.89M
Net Change in Cash (TTM)
-$17.43M
Filings
Filing Date
Wednesday, August 14, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Nov 11 and 15 (est)
Price History
Loading...
Beta
3.00
7-Day Total Return
-5.57%
30-Day Total Return
-0.26%
60-Day Total Return
33.56%
90-Day Total Return
-22.00%
Year to Date Total Return
5.69%
1-Year Total Return
130.77%
2-Year Total Return
-5.80%
3-Year Total Return
-72.57%
5-Year Total Return
--
52-week Low
Oct 26, 2023 - $1.11
52-week High
Apr 09, 2024 - $6.72
Valuation
Market Cap
$442.87M - Small Cap
Enterprise Value
$310.96M
Price/Sales (TTM)
135.89
Price/Book (Q)
2.00
Dividends and Shares
Shares Outstanding
112.93M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.absci.com
Phone Number
360 949 1041
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create... more
NASDAQ 09/13/2024 4:00PM Eastern Quotes delayed
Weiss Ratings